A$ 1.8
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Favourable price performance
About
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.
Target Price
The average target price of 4DX.AX is 1.5 and suggests 18% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
